Drugs that contain Megestrol Acetate

1. Drug name - MEGACE ES

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7101576 ENDO PHARMS INC Nanoparticulate megestrol formulations Apr, 2024

(1 year, 6 months from now)

US9101540 ENDO PHARMS INC Nanoparticulate megestrol formulations Apr, 2024

(1 year, 6 months from now)

US9107827 ENDO PHARMS INC Nanoparticulate megestrol formulations Apr, 2024

(1 year, 6 months from now)

US9040088 ENDO PHARMS INC Nanoparticulate megestrol formulations Apr, 2024

(1 year, 6 months from now)

US9101549 ENDO PHARMS INC Nanoparticulate megestrol formulations Apr, 2024

(1 year, 6 months from now)

Treatment: Treatment of anorexia, cachexia, or an unexplained, significant weight loss in patients with a diagnosis of acquired immunodeficiency syndrome (aids)

Dosage: SUSPENSION;ORAL

More Information on Dosage
Strength Dosage Availability
125MG/ML SUSPENSION;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.